Leadership & Staff


The BRI is led by three rotating directors and the Senior Vice President of Research. As members of the BRI Executive Committee (EC), these representatives are responsible for directing the BRI and for representing the BWH community inside and outside the institution.

Lisa Henske, MD

Marc Sabatine, MD

Past Director
Richard Blumberg, MD

Chief Academic Officer
Paul Anderson, MD, PhD

Executive Director
Jacqueline Slavik, PhD, MMSc

The BRI Research Oversight Committee

The BRI is governed by the Research Oversight Committee (ROC) which is made up of department representatives, BRI Center and Program Co-Chairs, and the BRI Executive Committee. The ROC was established to foster transparency and accountability in the decision-making process for the research enterprise and to plan new strategic initiatives.


James Rathmell, MD (Chair)
Greg Crosby, MD (Alternate)


Thomas S. Kupper, MD (Chair)
Tobias Schatton, PhD, PharmD (Representative)


Emergency Medicine
Michael VanRooyen, MD, MPH (Chair)
Daniel Pallin, MD, MPH (Representative)


Joseph Loscalzo, MD, PhD (Chair)
Nancy Berliner, MD (Representative)


Martin A. Samuels, MD (Chair)
Francisco Quintana, PhD (Representative)


Ennio A. Chiocca, MD, PhD (Chair)
Nathalie Agar, PhD (Representative)

Newborn Medicine
Terrie E. Inder, MBCHB (Chair)
Lianne Woodward, PhD (Representative)


Patricia Dykes, RN, DNSc, MA


Robert Barbieri, MD (Chair)
Cynthia Morton, PhD (Representative)


Orthopedic Surgery
James Kang, MD (Chair)
Julie Glowacki, PhD (Alternate)


Jeff Golden, MD (Chair)

Physical Medicine and Rehabilitation
Ross Zafonte, DO (Chair)


David Silbersweig, MD (Chair)
Hadine Joffe, MD (Representative)


Radiation Oncology
Daphne Adele Haas-Kogan, MD (Chair)
G. Mike Makrigiorgos, PhD, DABMP/DABR (Alternate)


Giles Boland, MD (Chair)
Nobuhiko Hata, PhD (Representative)


Gerard Doherty, MD (Chair)
Steve Mentzer, MD (Representative)
James Lederer,  PhD (Alternate)


Cancer Research Center
Jon Aster, MD, PhD


Cardiovascular, Diabetes & Metabolic Disorders Research Center
Mark Feinberg, MD
Marie McDonnell, MD
C. Keith Ozaki, MD


Connors-BRI Center for Research on Women’s
Health & Gender Biology
Jill Goldstein, PhD
Ursula Kaiser, MD


Genomics Center
Robert Green, MD, MPH
Calum MacRae, MD, PhD
Heidi Rehm, PhD
Christine Seidman, MD

Infectious and Immunologic Diseases Research Center
Ana Anderson, PhD
Rachael Clark, MD, PhD
Matthew Waldor, MD, PhD


Lung Research Center
Raphael Bueno, MD
Bruce Levy, MD
Edwin Kepner Silverman, MD, PhD


Musculoskeletal Research Center
Jeff Duryea, PhD
Nancy Ann Shadick, MD,MPH
Jessica Whited, PhD

Neurosciences Research Center
Phil DeJager, MD, PhD
Alexandra Golby, MD
Emily Stern, MD


Patient Centered Comparative Effectiveness Research Center
Elliot Israel, MD
Joel Weissman, PhD


Regenerative Medicine Research Center
Andreas Gomoll, MD
Richard T. Lee, MD


Pre-Clinical Models
Daniela Dinulescu, PhD
Cynthia Lemere, PhD
Arlene Sharpe, MD, PhD

Scott Weiss, MD

Biomedical Imaging
Clare Tempany, MD

Clinical Investigation
Danny Pallin, MD, MPH
Lindsey R. Baden, MD


Junior Faculty
Carleton Eduardo Corrales, MD
Basic Research


Kathryn Lynn Terry, SCD
Population Science


SeoYoung Kim, MD, ScD, MSCE
Clinical Research 

Senior Faculty
Fred Wang, MD
Basic Research


J. Danny Muehlschlegel, MD
Clinical Research


Howard D. Sesso, SCD, MPH
Population Science

Postdoctoral Fellows

Budhaditya Banerjee, PhD
Brian Sansbury, PhD
New alternate:  Stephania Libreros Ruiz, PhD

Additional Members

President, Brigham and Women’s Hospital
Elizabeth G. Nabel, MD


Harvard Catalyst Representative
Elliot Antman, MD


Susan Rapple, Chief Development Officer
Terrence McGowan, Assistant Vice President for Institutional Research
Linda Jones, Associate Vice President for Institutional Giving


Senior Science Communication Specialist
Haley Bridger


Chief Academic Officer, Partners HealthCare
Anne Klibanski, MD


Thomas Michel, PhD


CIMIT Site Miner, BWH
Frederick Schoen, MD, PhD
Kirby Vosburgh, PhD


Partners Innovation
Chris Coburn
Jon Behr
Pat Fortune
Phil Licari


Vicki Amalfitano


Partners Research Management
Andrew Chase


Center for Faculty Development and Diversity
Helaine Friedlander


Research Administration and Compliance
Allison Moriarty


Brigham Education Institute 
Erik K. Alexander, MD, FACP


BWH Translational Accelerator 
Lina Williamson, DVM PhD


BWH Institute for the Neurosciences
Adrian J. Ivinson, PhD


Srinivasan Mukundan, Jr.,MD, PhD

Scientific Advisory Board

James Bradner, MD
Novartis Institutes for BioMedical Research (NIBR), Novartis


Carol Greider, PhD
Daniel Nathans Professor and Director
Department of Molecular Biology and Genetics, Johns Hopkins


Susan Hockfield, PhD
President Emerita and Professor of Neuroscience
Massachusetts Institute of Technology (MIT)


Jeff Leiden, MD, PhD
CEO, Director & President
Vertex Pharmaceuticals


Terry McGuire, MBA, MS
Co-Founder and General Partner


Michael Rosenblatt, MD
Chief Medical Officer
Flagship Ventures


Sue Siegel, MS
‎CEO, GE Ventures, Licensing & Healthymagination
General Electric (GE)


Geoff Smith, JD
Managing Partner
Digitalis Ventures

The BRI Administrative Staff


Dr. Jacqueline M. Slavik is the executive director of the Brigham Research Institute (BRI) at Brigham and Women’s Hospital. In this role she shapes and implements the BRI’s overarching mission to accelerate discoveries that improve human health by fostering groundbreaking, interdepartmental, and interdisciplinary research, ranging from basic fundamental studies to clinical innovations.  She manages a team who works to provide a clear voice for the entire BWH research community, raise the profile of research at BWH, develop mission-centric collaborations with external entities and engage the scientific community in fundraising. Dr. Slavik received her PhD in Immunology from Harvard University, a Master of Medical Science from Harvard University and a BS in Biology from State University of New York at Albany. Dr. Slavik did her postdoctoral fellowship in the Center for Neurologic Diseases in the Department of Neurology at BWH, and held a faculty appointment as instructor in Neurology at Harvard Medical School prior to transitioning to the role of senior program manager at the BRI, from which she moved into her current leadership role. Her research interests include T lymphocytes and T lymphocyte signaling and their involvement in cancer and autoimmune diseases such as multiple sclerosis.


Dr. Anu Swaminathan serves as the Director for Scientific Programs and Partnerships at the Brigham Research Institute (BRI). In this role, she drives a broad range of activities related to the BRI’s multiple research centers, programs and other pan-institute initiatives with the ultimate goals of increasing the visibility of the exciting research happening at BWH and catalyzing fundraising for the same in order to fuel the discovery and innovation engine of the hospital. As part of this mandate, she leads efforts to establish new research collaborations within BWH as well as with external entities including industry; diversify the funding portfolio of researchers and clinician scientists and; foster institutional involvement and community building within the hospital’s research fraternity. Anu has a PhD in Biochemistry from the University of Connecticut and brings an eclectic blend of professional experiences spanning basic research, technology commercialization, policy making and administration to her current role.


Elana Wilner is the Program Coordinator at the Brigham Research Institute. Her role focuses on event logistics, pre-event communications for internal and external groups and onsite coordination for the centers and programs that make up the BRI.  Elana Graduated from University of Delaware in 2013, with a degree in Hotel, Restaurant and Institutional Management.


Alexandra Gallant is the Web Media Manager & Creative Designer at the Brigham Research Institute. Her role is focused on identifying ways to use visual communication tools to support the efforts of the research community.  With an emphasis on user experience and design standards,  she provides creative direction for all BRI initiatives, including the development of research web sites, email communication  vehicles and print collateral.  She studied Criminal Justice and English at Northeastern University.  She is also an accomplished artist and illustrator.

Amanda Czechowski

Amanda Czechowski is the Web & Communications Coordinator at the Brigham Research Institute. She manages the operations for the development of new research websites for laboratories and research groups, and assists with a range of online communication efforts directed at both internal and external audiences. Amanda graduated from Bridgewater State University in 2010, with a degree in Graphic Design & Communication Studies.

Administrative Coordinator

Sara Yohannes is the Administrative Coordinator at the Brigham Research Institute (BRI). Sara provides administrative, financial, and event support at the BRI. As the Administrative Coordinator she is the gatekeeper of information. She came to us from the Brigham and Women’s Orthopedic and Arthritis Center in August of 2014. Sara graduated from Suffolk University with a Bachelor of Science in Business Administration in 2012.


Dr. David serves as Innovation Strategist at the BRI, in addition to being Founder and Managing Director of Pharmagellan, a Boston-area biotech consulting firm.


After studying molecular biophysics and biochemistry at Yale, Dr. David received his M.D. and Ph.D. degrees from Columbia University’s College of Physicians and Surgeons. Dr. David completed his clinical training in anatomic pathology at Brigham and Women’s Hospital, and then served as Instructor in Pathology at Harvard Medical School and Brigham and Women’s, where he researched cell signaling in cancer and kidney development.

As Director in the consulting arm of Leerink Partners, a leading healthcare investment bank, Dr. David led advisory engagements for corporate, commercial, R&D, business development, and investor clients across all major therapeutic areas and business sectors, including biopharma, devices, diagnostics, life sciences tools, and healthcare services. He also co-founded Leerink’s Transactional Consulting practice, which advised financial and strategic investors and early-stage companies side-by-side with Leerink’s investment banking team. Dr. David also served as Director of Strategy in AstraZeneca’s Oncology Innovative Medicines unit, where he led business strategy efforts from target identification through Phase 2a, spearheaded initiatives in end-to-end franchise strategy and portfolio valuation, led external communications focused on R&D collaborators and investors, and provided commercial support to pipeline projects and in-licensing teams.


Dr. David writes about biomedical innovation at Forbes.com and the Pharmagellan blog, and maintains an active presence on Twitter (@Frank_S_David).